Archive - March 2021
Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition
FDA to review Sanofi/Regeneron’s Dupixent in children with uncontrolled asthma
Lilly’s tirzepatide claims head-to-head trial win against injectable semaglutide
ClinSpec Diagnostics reaches funding target of £3.5m
Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA
Can The FDA Keep Pandemic Fraudsters at Bay?